These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29202245)

  • 1. Chemical and Physical Variability in Structural Isomers of an l/d α-Sheet Peptide Designed To Inhibit Amyloidogenesis.
    Maris NL; Shea D; Bleem A; Bryers JD; Daggett V
    Biochemistry; 2018 Feb; 57(5):507-510. PubMed ID: 29202245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
    Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
    Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides Composed of Alternating L- and D-Amino Acids Inhibit Amyloidogenesis in Three Distinct Amyloid Systems Independent of Sequence.
    Kellock J; Hopping G; Caughey B; Daggett V
    J Mol Biol; 2016 Jun; 428(11):2317-2328. PubMed ID: 27012425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
    Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality.
    Turner JP; Chastain SE; Park D; Moss MA; Servoss SL
    Bioorg Med Chem; 2017 Jan; 25(1):20-26. PubMed ID: 27776890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.
    Goyal D; Shuaib S; Mann S; Goyal B
    ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies.
    Robinson M; Lou J; Mehrazma B; Rauk A; Beazely M; Leonenko Z
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Design for Dual Modulation Effect of Amyloid Protein Aggregation.
    Zhu L; Song Y; Cheng PN; Moore JS
    J Am Chem Soc; 2015 Jul; 137(25):8062-8. PubMed ID: 26043045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A discrete mathematical model for the aggregation of β-Amyloid.
    Dayeh MA; Livadiotis G; Elaydi S
    PLoS One; 2018; 13(5):e0196402. PubMed ID: 29791461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.
    Arai T; Sasaki D; Araya T; Sato T; Sohma Y; Kanai M
    Chembiochem; 2014 Nov; 15(17):2577-83. PubMed ID: 25262917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not Oligomers but Amyloids are Cytotoxic in the Membrane-Mediated Amyloidogenesis of Amyloid-β Peptides.
    Itoh N; Takada E; Okubo K; Yano Y; Hoshino M; Sasaki A; Kinjo M; Matsuzaki K
    Chembiochem; 2018 Mar; 19(5):430-433. PubMed ID: 29235220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-situ side-chain peptide cyclization as a breaker strategy against the amyloid aggregating peptide.
    Ghosh N; Kundu LM
    Bioorg Med Chem; 2021 Mar; 33():116017. PubMed ID: 33486160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isomeric Effect of Nano-Inhibitors on Aβ
    Li J; Gao G; Tang X; Yu M; He M; Sun T
    ACS Appl Mater Interfaces; 2021 Feb; 13(4):4894-4904. PubMed ID: 33486955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyroglutamylated amyloid-β peptide reverses cross β-sheets by a prion-like mechanism.
    Matos JO; Goldblatt G; Jeon J; Chen B; Tatulian SA
    J Phys Chem B; 2014 May; 118(21):5637-43. PubMed ID: 24802697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease.
    Jang JY; Rhim H; Kang S
    Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):71-80. PubMed ID: 29107146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
    Gao N; Sun H; Dong K; Ren J; Qu X
    Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.
    Liu Y; Cong L; Han C; Li B; Dai R
    Mini Rev Med Chem; 2021; 21(8):969-990. PubMed ID: 33245270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.